Excel4apps announced that CardioDX, a Healthcare industry organization based in California,USA have selected GL Wand to complement their Oracle Financial reporting toolset.
Founded in 2004, CardioDx®, Inc. is a cardiovascular genomic diagnostics company located in Palo Alto, CA. As a pioneer in the field of cardiovascular genomic diagnostics, the company is committed to developing clinically validated tests that empower clinicians to better tailor care to each individual patient. Strategically focused on coronary artery disease, cardiac arrhythmia, and heart failure, CardioDx is poised to expand patient access and improve healthcare quality and efficiency through the commercialization of genomic technologies.
CardioDx was recently honored as one of FierceMedicalDevices' Fierce 15 most promising private companies. Earlier in the year, CardioDx was named the 2012 Gold Edison Award winner for science and medical. In 2010, the company was honored as a winner of the Wall Street Journal’s prestigious Technology Innovation Awards and Corus® CAD was named one of Time Magazine’s Top Ten Medical Breakthroughs.
CardioDx is a privately held company funded by Kleiner, Perkins, Caufield & Byers, TPG Biotech, Mohr Davidow Ventures, Intel Capital, Pappas Ventures, DAG Ventures, Asset Management Company, GE Capital, Longitude Capital, JP Morgan Venture Capital, Acadia Woods Partners, Artiman Ventures, Bright Capital, and Temasek.
For more information on CardioDX please visit www.cardiodx.com
For more information on 3RP the transaction partner please visit www.3rp.com